Napralief (Naproxen)

Naproxen, the active ingredient in Napralief, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an oral tablet for oral use. It is employed to relieve pain, reduce inflammation, and lower fever in adults with conditions such as arthritis, menstrual cramps, and mild to moderate acute pain.

GNH USA supplies Napralief as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Naproxen acts on inflammatory pathways and is indicated for several painful and inflammatory conditions.

- Mild to moderate pain: relief of acute pain such as headache, dental pain, or musculoskeletal discomfort. - Osteoarthritis: reduction of joint pain and improvement of mobility. - Rheumatoid arthritis: control of inflammation and slowing of disease‑related joint damage. - Dysmenorrhea: alleviation of menstrual cramp pain. - Fever: reduction of elevated body temperature associated with infection or inflammation.

Naproxen may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Nausea: mild stomach upset. - Dyspepsia: heartburn or indigestion. - Headache: transient headache episodes. - Dizziness: light‑headed feeling.

Serious or Rare Side Effects: - Gastrointestinal ulcer or bleeding. - Severe skin reactions such as Stevens‑Johnson syndrome. - Kidney function impairment.

When prescribing naproxen, clinicians should consider several safety measures to minimize risk.

- Assess gastrointestinal risk: evaluate history of ulcers or bleeding. - Monitor cardiovascular risk: use caution in patients with heart disease. - Evaluate renal function: adjust use in impaired kidney function. - Use the lowest effective dose: limit duration to the shortest necessary period. - Avoid in known hypersensitivity: discontinue if allergic reaction occurs. - Store at ambient temperature: keep in the original pack, protect from moisture.

Naproxen can interact with other medicines, altering efficacy or safety.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased bleeding risk. - SSRIs (e.g., fluoxetine): heightened gastrointestinal bleeding. - Lithium: elevated lithium levels.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: possible reduction in renal function. - Diuretics: may enhance nephrotoxic potential.